What Algisys does

Algisys BioSciences is a privately held B2B ingredients supplier founded in 2009 and headquartered in Akron/Cleveland, Ohio. The company produces vegan algal EPA omega-3 oils — marketed under the AlgiGOLD brand — and a high-protein vegan biomass branded as Green Protein, both derived from proprietary strains of microalgae grown via heterotrophic fermentation in traditional industrial fermentation equipment. This fermentation-based approach is positioned as the first commercial-scale algal EPA production process and is designed to displace fish oil as the primary source of EPA omega-3 fatty acids.

The company sells its ingredients directly to enterprise manufacturers across seven end markets: dietary supplements, human nutrition, animal and pet nutrition, aquaculture, pharmaceuticals, food & beverage, and cosmetics. Its go-to-market is direct enterprise field sales, with an initial focus on the supplement and aquaculture/animal-feed verticals followed by staged expansion into Pharma, F&B, and cosmetics. Revenue mechanics are framed as one-time ingredient sale transactions; pricing is not publicly disclosed. Algisys protects its position with seven international patents covering strains and processes, a registered AlgiGOLD trademark, and trade-secret-protected strain genetics, and differentiates on sustainability, non-GMO, halal-certified, and high-purity positioning.

Algisys has raised approximately $7 million in Series A funding led by founding Director Michael Finn, supplemented by additional disclosed rounds of roughly $200K (2011), $2.5M (2012), and $6.15M (2013). It is currently pre-commercial-scale, with 1–10 employees, and is in the planning phase for a $75 million fermentation manufacturing facility in Saudi Arabia anchored by MOUs with the Ministry of Investment of Saudi Arabia (MISA) and participation in KAUST's Destination Deep Tech Program. Revenue figures are not disclosed in the source data.

Name

Algisys

Legal name

AlgiSys, LLC

Website

https://algisys.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

Algisys BioSciences is a privately held B2B ingredients company that produces vegan algal EPA omega-3 oils and high-protein vegan biomass via proprietary heterotrophic fermentation, supplying manufacturers across nutrition, aquaculture, pharmaceutical, food & beverage, and cosmetics markets.

Ownership category

akta.pro rank

Product category

Algal Omega-3 and Plant Protein Ingredients

NAICS

Starch and Vegetable Fats and Oils Manufacturing (31122), Animal Food Manufacturing (31111)

SIC

Fats & Oils (2070)

akta.pro primary industry

Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors) (EUAAAIAJ)

akta.pro secondary industries

Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae) (AFAJAHAF), Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast) (EUAAAIAI), Plant-Based & Vegetarian/Vegan Nutrition (HSADAFAJ)

Keywords

• Algal omega-3 oils
• Algal EPA production
• Plant-based protein
• Microalgae fermentation
• Nutritional ingredients

Headquarters

HQ city

Cleveland

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Algal EPA Omega-3 Oil Sales: Sale of algal EPA omega-3 nutritional oils to supplement, pharmaceutical, food & beverage, and cosmetics manufacturers. Initially targeting supplement and human/animal/pet nutrition markets, followed by Pharma, Food & Beverage and cosmetics markets.
2. Plant Protein (Green Protein) Sales: Sale of high protein vegan biomass derived from algae after oil extraction and drying. Targets plant-based protein market expected to grow from $18.5 billion to exceed $40 billion by 2025.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Algisys manufactures and sells vegan algal EPA Omega-3 nutritional oils and high-protein vegan biomass (Green Protein) produced from proprietary microalgae strains via heterotrophic fermentation. The products target supplement, human/animal/pet nutrition, aquaculture, pharmaceutical, food and beverage, and cosmetics manufacturers as a sustainable, non-GMO, halal-certified replacement for fish oil.

Product overview

AlgiSys is a BioFoodTech company commercializing patented algal technologies to produce EPA Omega-3 and plant protein products. The core product portfolio consists of AlgiGOLD (algal EPA oil), EPA Omega-3 Nutritional Oils, and Green Protein (vegan biomass). The company uses proprietary strains of microalgae and commercial fermentation technology to produce all-natural, non-GMO, halal, and sustainable omega-3 products that replace fish oil as the primary source, initially targeting the supplement, human, animal, pet nutrition, and aquaculture markets, followed by pharma, food & beverage, and cosmetics markets.

Differentiator

Problem solved

Functional benefit

Products and services

• AlgiGOLD Algal EPA Omega-3 oil product derived from proprietary strains of microalgae using patented fermentation technology. It is a cost-effective, vegan, and sustainable omega-3 supplement with exceptionally high purity standards, isolated from outside pollutants and impurities found in traditionally sourced omega-3, sold to supplement, pharmaceutical, food and beverage, and cosmetics manufacturers.
• EPA Omega-3 Nutritional Oils All-natural EPA Omega-3 nutritional oils produced from proprietary strains of microalgae using heterotrophic fermentation technology. The first commercial algal EPA production process designed to cost-effectively produce this omega-3 fatty acid, replacing fish oil as the primary source for supplement, pharmaceutical, food and beverage, and cosmetics manufacturers.
• Green Protein (Vegan Biomass) High protein vegan biomass derived from algae strains after oil extraction and drying. Proprietary algae growth and production methods are optimized to attain the highest protein and EPA oil output, offering health benefits including improved digestion, boosted metabolism, and cardiovascular health without added hormones or antibiotics, sold to nutrition, supplement, food and beverage, and animal feed buyers.

Quantifiable outcome

• 1.8 trillion Peruvian Anchovies Saved over 7-year period
• +3 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core.

• Strameno Ltd.coreStrategic or Co-development PartnerStrategic partnership through Memorandum of Understanding between Strameno Ltd. (UK) and AlgiSys Biosciences Inc. (USA). Both companies work at cutting edge of algae technologies. Strameno brings expertise in DHA and niche algae strains combined with AlgiSys expertise in algae commercialization and fermentation technology. Partnership enables creation of new products to supply expanding market for omega-3s, antioxidants, and plant protein, expanding beyond EPA into carotenoids and DHA.
• KAUST (King Abdullah University of Science and Technology)coreStrategic or Co-development PartnerAlgiSys selected for KAUST Destination Deep Tech Program - a competitive 3-month program for companies with disruptive technology. AlgiSys is one of only 11 companies selected from a large global pool. Program provides access to world-renowned researchers, unique infrastructure and technology expertise. Technology aligns with Kingdom's 2030 food security and self-sufficiency goals. Dr. Charles Roe will be based at KAUST in Saudi Arabia for 3 months to develop applications and build local partnerships.
• Ministry of Investment of Saudi Arabia (MISA)coreStrategic or Co-development PartnerMemorandum of Understanding signed with MISA to support food security and health and wellness in the Kingdom. Partnership will facilitate building a manufacturing facility in Saudi Arabia to produce EPA Omega 3s and plant protein from micro-algae. Plant will create local employment and target domestic markets as well as exports to Middle East and Europe. Aligned with Vision 2030 goals.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Corbion: Global food ingredients company that acquired TerraVia (formerly Solazyme) and now produces algae-derived DHA omega-3 (AlgaDHA). Directly comparable fermentation-based algae platform serving nutrition and food customers.
• Veramaris: Joint venture between DSM and Evonik producing algal EPA/DHA omega-3 oils for aquaculture and pet food. Most direct head-to-head competitor to Algisys in commercial-scale algal omega-3 with established blue-chip customer base.
• Cyanotech: Public US company producing high-value microalgae-based products (Spirulina, Hawaiian Astaxanthin) for the supplements and nutrition markets. Comparable in using proprietary algae cultivation to make premium ingredients for human nutrition channels.
• BGG World: Algae-based ingredient producer supplying natural astaxanthin, beta-glucan, and other microalgae-derived nutrition ingredients. Closely comparable business model — algal biomass fermentation into specialty nutrition ingredients — and notably Charles Bowman (Algisys board member) was a prior C-level executive at BGG.

Broad incumbents

• dsm-firmenich: Global nutrition, health and ingredients giant and parent of the Veramaris JV. Operates broadly across animal nutrition, human nutrition, and personal care with established omega-3 and vitamin franchises — sets the competitive benchmark that Algisys must outperform on cost and purity.
• ADM: Global agricultural processor and nutrition ingredient supplier with significant plant-based protein and specialty ingredient capabilities. Comparable in serving CPG and feed customers seeking plant-based and sustainable ingredient alternatives to animal-derived inputs.
• Cargill: One of the world's largest agribusinesses with deep animal nutrition and aquaculture feed businesses, including omega-3 ingredients. Relevant comparable for go-to-market in animal feed/aquaculture channels and for acquisition as a strategic exit pathway.

Emerging players

• Heliae Development: US-based algae technology company developing microalgae-based products for agriculture, nutrition, and aquaculture. Similar early-to-growth stage profile to Algisys, focused on translating proprietary algae cultivation into commercial ingredient products.
• Photonz: New Zealand-based company producing EPA and DHA omega-3 from fermentation of microalgae, serving nutraceutical and aquafeed markets. Closely comparable in scale, technology approach (fermentation-derived omega-3), and target customer segments to Algisys.

Regional players

• BioMar: Among the world's largest aquaculture feed producers, headquartered in Norway with strong European and Latin American presence. A potential anchor customer and competitor for omega-3 supply into farmed fish feed, particularly relevant given Algisys' aquaculture feed focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/algisys-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Algisys